Scarica l'app Stockscreener
0.00
100.00%
-135.07
Apogee Therapeutics Inc Borsa (APGE) Ultime notizie
What Does the Apogee Therapeutics Deal Add for AbbVie (NYSE:ABBV)? - Kalkine Media
Apogee Therapeutics, Inc. SEC Filing (Sep 14, 2026) - Stock Titan
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth? - Yahoo Finance
APOE THERPAR: Shareholders Board Members Managers and Company Profile | US03770N1019 - marketscreener.com
Fairmount Funds Management LLC Exits Apogee Therapeutics Inc (AP - GuruFocus
Apogee Therapeutics (NASDAQ: APGE) leaves Nasdaq in AbbVie cash buyout - Stock Titan
AbbVie Inc. stock holds near highs as Apogee deal and guidance support sentiment - AD HOC NEWS
Michael Henderson: A New Chapter Begins for Apogee Therapeutics With AbbVie - Oncodaily
Fairmount Funds Management Exits Apogee Therapeutics (NASDAQ: APGE) Following $135.11 Per Share Merger Payout - Kalkine Media
Apogee Therapeutics Completes Merger and Plans Nasdaq Delisting - The Globe and Mail
AbbVie-owned Apogee Therapeutics (APGE) pulls unsold stock - Stock Titan
Apogee Therapeutics (APGE) director-linked funds fully exit in AbbVie deal - stocktitan.net
Apogee Therapeutics (APGE) CMO cashes out stock and options in AbbVie deal - Stock Titan
Apogee (APGE) director’s shares and options cashed out in AbbVie deal - Stock Titan
Apogee merger pays $135.11 per share in cash | APGE SEC FilingForm SCHEDULE 13D/A - Stock Titan
AbbVie Completes $10.9 Billion Acquisition Of Apogee Therapeutics - Pulse 2.0
AbbVie (ABBV) Completes Acquisition of Apogee Therapeutics - GuruFocus
AbbVie Finalizes $10.9 Billion Acquisition of Apogee Therapeutics, Initiates Nasdaq Delisting - Kalkine Media
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline - Dermatology Times
AbbVie Completes Acquisition of Apogee Therapeutics - Investing News Network
Apogee Therapeutics (Nasdaq: APGE) loses its Nasdaq listing - Stock Titan
ABBV Looks 19.1% Overvalued on GF Value™ Amid $10.9B Apogee Acqu - GuruFocus
AbbVie seals $11B acquisition of Apogee Therapeutics (ABBV:NYSE) - Seeking Alpha
Apogee Therapeutics Announced Transfer or Voluntary Withdrawal of Listing - TradingView
AbbVie’s $10.9 billion deal adds a late-stage eczema treatment - Stock Titan
Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Apogee Therapeutics, Inc.(NasdaqGM: APGE) dropped from S&P Global BMI Index - marketscreener.com
Apogee Therapeutics, Inc.(NasdaqGM: APGE) dropped from S&P TMI Index - marketscreener.com
Apogee Therapeutics, Inc.(NasdaqGM: APGE) dropped from NASDAQ Composite Index - marketscreener.com
APGE Stock Price, Quote & Chart - ChartMill
Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Apogee Therapeutics, Inc.(NasdaqGM: APGE) dropped from Russell 2500 Index - marketscreener.com
Apogee Therapeutics stock hits all-time high at 134.89 USD - Investing.com
Apogee Therapeutics Market Sentiment - Benzinga España
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year HighShould You Buy? - MarketBeat
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
NINE MASTS CAPITAL Ltd Takes Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Weekly Recap: $1.3B cash, $85.9M loss and directors resign on AbbVie deal - TradingView
What Will Apogee Therapeutics (NASDAQ:APGE) Say on Trials? - Kalkine Media
Alberta Investment Management Corp Purchases New Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics CMO Dambkowski sells $737k in stock By Investing.com - Investing.com Nigeria
Apogee Therapeutics CMO Dambkowski sells $737k in stock - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Liquidity Mapping Around (APGE) Price Events - news.stocktradersdaily.com
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Handelsbanken Fonder AB Has $11.46 Million Stake in Apogee Therapeutics Inc. $APGE - MarketBeat
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Sahm
Truist Financial Maintains Apogee Therapeutics(APGE.US) With Hold Rating, Raises Target Price to $135 - Moomoo
Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History - Yahoo Finance
Apogee Therapeutics Director Vote: My Take On The 8-K Liga Mx (YjhKcvC1lD) - Mshale
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by BTIG Research - MarketBeat
APGE Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus
BTIG Downgrades Apogee Therapeutics to Neutral From Buy - marketscreener.com
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal By Investing.com - Investing.com South Africa
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal - Investing.com Nigeria
Apogee Therapeutics Directors Execute Stock Options, Increasing Holdings - Kalkine Media
Apogee Therapeutics (APGE): Fairmount-linked funds exercise 42,208 options - Stock Titan
Apogee Therapeutics, Inc. Announces Board and Committee Changes - marketscreener.com
Apogee Therapeutics,Q2 2026 Net Loss $85.9 - Moomoo
My Takeaway On Apogee Therapeutics' Massive Cash Raise Humberto Cruz (GVA0ZiS739) - Mshale
Apogee Therapeutics, Inc. (APGE): An Insightful Stock Analysis on Growth Potential and Market Position - DirectorsTalk Interviews
APGE SWOT Analysis: Financial Resilience Amidst Clinical Challenges Revealed in 10-Q Filing - GuruFocus
Apogee Therapeutics Reports Q2 2026 Results and Announces Merger Agreement with AbbVie Subsidiary - Kalkine Media
Apogee Therapeutics 2Q 2026: Net loss $85.9M, First half loss $160M — 10-Q Summary - TradingView
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):